• Kin Health

  Participated · Seed · May 2026

  Kin Health builds a patient-facing AI notetaker that records doctor visits, transcribes conversations using specialized medical models, and returns user-facing summaries with action items and next steps. The app encrypts patient data and is private by default; it is not HIPAA-certified but the company says it adheres to the same privacy standards. Founders are physicians Arpan and Amit Parikh and Kyle Alwyn, with GoodRx co-founders Doug Hirsch and Trevor Bezdek as founding partners and executive chairmen. Kin says it evaluates outputs at multiple processing stages to improve accuracy and is working to handle different accents and challenging audio conditions. The company plans to bring in additional health data sources this year, including physicians’ notes via EHR integrations, and will keep the app free while monetizing through referrals to specialists and labs. The product faces industry concerns around AI accuracy, consent, and data security, and Kin notes clinicians should review AI-generated documentation.

• Sokin

  Participated · Series B · Dec 2025

  Founded in 2019, Sokin provides businesses with access to more than 70 currencies for transfers and exchanges, the ability to hold balances in 26 currencies via multi-currency IBAN and local accounts, and transaction capabilities across 170+ countries. Its platform serves both direct business clients and partners who embed Sokin’s infrastructure into their own offerings, addressing demand for integrated, end-to-end payment workflows. The company has maintained 100% year-on-year revenue growth while remaining profitable and was named one of The Sunday Times’ fastest-growing technology companies. Headquartered in the United Kingdom, Sokin operates additional offices in Australia, the United States, Canada, the United Arab Emirates, Singapore, Mexico, Norway, and India. Recent product roadmaps include expanding embedded payments features and scaling global infrastructure. Management reports that the fresh capital lowers borrowing costs, positions Sokin to secure additional regional licenses, and supports further geographic expansion across North America, Asia, the Middle East, and South America. The firm services clients across diverse verticals, from freight and logistics to Premier League football clubs.

• Baselane

  Participated · Series B · Oct 2025

  Baselane offers a comprehensive financial platform purpose-built for rental property owners, combining banking, automated bookkeeping, tax reporting, and rent collection in one solution. More than 50,000 independent real-estate investors use the service, processing over $2 billion annually through the platform. By automating core financial tasks, Baselane enables landlords to save time, operate more efficiently, and expand their rental portfolios. Led by CEO Mathias Korder, the company plans to channel new capital into scaling its go-to-market efforts and accelerating product innovation. Investor enthusiasm has helped the firm raise $44.3 million in total, highlighting confidence in its growth potential. Baselane aims to further transform how individual real-estate investors manage and grow their businesses through continued product enhancements and market expansion.

• Penguin Ai

  Participated · Series A · Sep 2025

  Penguin Ai’s flagship platform combines task-specific Small Language Models (SLMs), proprietary language models, APIs and out-of-the-box Digital Workers and Agents to automate back-office healthcare workflows such as medical coding, prior authorizations, claims adjudication, appeals management, risk adjustment, chart summarization and payment integrity. The company emphasizes a full-service platform approach rather than point solutions, including tooling to prepare data for AI, pre-built healthcare LLMs, and governance and bias-correction capabilities for security and fairness. Penguin Ai says it has secured key partnerships with health plans, providers and technology organizations and is collaborating with customers to accelerate development of its enterprise-grade platform. Leadership is led by founder and CEO Fawad Butt, the former chief data officer of UnitedHealthcare, Kaiser Permanente and Optum, and the team brings collective experience from major payer, provider and tech organizations. The company positions its technology to reduce the industry’s estimated $1 trillion administrative burden and to lower operational costs while improving accuracy and efficiency. Penguin Ai plans to use recent funding to support hiring, product development, and scaling deployments with payers and providers.

• Valera Health

  Participated · Equity · Oct 2022

  Valera Health operates a virtual behavioral healthcare practice that delivers comprehensive, longitudinal care through a team-based model of licensed therapists, nurse practitioners, case managers and psychiatrists augmented by proprietary digital technology and analytics. The company emphasizes evidence-based treatment plans and a quality strategy aligned to NCQA HEDIS measures to manage patients across acuity levels, from mild depression to schizophrenia. Valera partners closely with health systems and health plans, and its payer/provider partnerships collectively cover over 50 million lives. It offers culturally-intentional care to BIPOC and LGBTQ+ communities via a diverse, multilingual provider network in which more than 50% of clinicians self-identify as Black, Hispanic, or Asian. Valera says the financing will enable expansion of access to high-quality behavioral health care and deepen partnerships with leading health systems and health plans. The company closed a $44.5M growth equity round in late 2022 as part of its current financial position. Valera Health is a NYC-based mental health company delivering tech-driven virtual services. It provides comprehensive longitudinal care via a team-based model of coaches, therapists, and medication prescribers augmented by proprietary digital technology and analytics. The company treats conditions ranging from mild depression to severe schizophrenia and offers personalized, culturally intentional care for rural and urban communities, including BIPOC and LGBTQ+ patients, through a diverse, multilingual provider network. Over the past twelve months Valera has partnered with health plans and provider groups covering over 12 million lives. Valera intends to use the newly raised $15M to expand operations and business reach and will be expanding to multiple states in the coming months. The company is led by co-founder and CEO Dr. Thomas Tsang. Valera Health is a Brooklyn, N.Y.-based tele-behavioral health service that delivers longitudinal, team-based clinical care using coaches, therapists and medication prescribers augmented by proprietary digital technology. Its care model provides personalized treatment across a spectrum from meditation to therapy to medications for patients with mild depression to severe schizophrenia. The multidisciplinary care team includes licensed social workers, mental health counselors, nurse practitioners, and psychiatrists. The company is led by CEO and co-founder Thomas Tsang, MD. Valera plans to use new capital for strategic market expansion and to grow existing services. The articles report total funding to date of $9M following the latest raise.

No current team members are available.